Johan Wedell-Wedellsborg, Director at Y-mAbs Therapeutics, Inc. (YMAB), sold 63,728 shares at $35.57 ($2.3M) on 2021-06-01, disclosed to the SEC on 2021-06-02.
Open-market sale of $2.3M YMAB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.34 | 25,000 | $909K | 39.4% |
| 2 | $36.34 | 25,000 | $909K | 39.4% |
| 3 | $35.57 | 6,864 | $244K | 10.6% |
| 4 | $35.57 | 6,864 | $244K | 10.6% |
| Total | $36.17 avg | 63,728 | $2.3M | 100% |
| Filing → |
| YMAB | BUY | 2023-12-01 | $619K | — | Filing → |
| YMAB | BUY | 2023-11-29 | $1.0M | — | Filing → |
| YMAB | BUY | 2023-05-17 | $982K | — | Filing → |